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We commend the FluoroCouncil for phasing
out long-chain poly- and perfluoroalkyl substance (PFAS) chemistry. However, members
of the FluoroCouncil have been producing
long-chain PFASs for decades while in possession of research showing adverse health
effects in humans and animals. This model of
chemical manufacturing needs to change. We
recommend implementing the principles of
green chemistry (Anastas and Warner 1998)
in chemical manufacturing to ensure safer and
sustainable chemical products. The scientific
consensus of the Madrid Statement authors
and signatories is that the use of all PFASs is
unsustainable, and can and should be greatly
reduced and discontinued where feasible.
Short-chain fluorinated alternatives were therefore intentionally included in the scope of the
Madrid Statement.
Some of the functionalities provided by
fluorotechnology have become part of modern life. However, we disagree that PFASs
are critical to modern life. Sustainable and
less hazardous alternatives are available for
many functionalities, and others will be
developed. PFAS-based chemistries are used
in many nonessential applications such as
clothing, sports equipment, food packaging
materials, blooming and dispersion agents,
and stain-repellant treatments. We urge the
FluoroCouncil to provide as much information as possible on the PFAS chemistries used in different commercial products
and technologies.
We are aware that short-chain perfluoro
alkyl acids bioaccumulate less than longchain ones. However, some short-chain
PFASs have been linked to adverse biological
effects (Bull et al. 2014), and further systematic, representative studies on additional
end points are needed. Given the ongoing
release and environmental persistence of
short-chain acids, increasing environmental
and human exposures such as those documented by Glynn et al. (2012) are expected,
for example, via contaminated drinking water
aquifers (Xiao et al. 2015). Thus, continuous
release of short-chain PFASs can be expected
to lead to poorly reversible internal exposures, regardless of their low bioaccumulation
potential (Scheringer et al. 2014).
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Bowman commented that the Madrid
Statement cannot claim insufficient data on
the hazards and risks of fluorinated alternatives. However, Wang et al. (2015) highlighted the specific data gaps that prohibit
conducting hazard and risk assessments for
many fluorinated alternatives. An assessment commissioned by the FluoroCouncil
(ENVIRON International Corporation
2014) also identified many gaps regarding
human health data.
Bowman stated that “decisions on the
societal acceptability of strategic materials such as PFASs cannot be wisely made
on a single attribute such as persistence.”
However, persistent chemicals are unsustainable in a world with limited resources. We
cannot afford to “lose” portions of resources
(water, soil, or food) because potentially
harmful and persistent chemicals are accumulating over centuries and causing continuous exposure. Because of their persistence,
an enormous inventory of PFASs is being
created: Even if all PFAS production and
uses were to stop immediately, PFASs would
continue to be released for decades during
products’ use and disposal life-cycle phases
(Wang et al. 2014a, 2014b). One of the
12 principles of green chemistry is “design
for degradation: chemical products should
be designed so that at the end of their function they break down into innocuous degradation products and do not persist in the
environment” (Anastas and Warner 1998).
We endorse this principle and urge the
FluoroCouncil to follow it also.
We welcome collaboration with the
FluoroCouncil to establish informationsharing platforms for PFASs and support
all opportunities for dialogue. We ask the
FluoroCouncil to take leadership and responsibility for the global management of the
PFASs they produce, from manufacturing to
end of life.
The authors declare they have no actual or
potential competing financial interests.
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The FluoroCouncil’s voluntary development of alternative chemistries is unprece
dented and a model for the development
and introduction of more sustainable
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chemistry worldwide. More than a decade
ago, the FluoroCouncil member companies
responded to concerns about long-chain
poly- and perfluoroalkyl substances (PFASs)
by working with regulators to voluntarily
phase out those substances and develop alternatives with improved health and environ
mental profiles. The FluoroCouncil also
works with regulators and other stakeholders to support a global transition away from
long-chain PFASs. This effort stands as a
historic collaboration by government and
industry to foster sustainable development.
The claim that all PFASs are problematic
is simply not supported by the wealth
of data available on both long- and shortchain PFASs. Because of the concerns raised
in regard to long-chain PFASs, the U.S.
Environmental Protection Agency (EPA) has
held the fluorotechnology industry to high
standards and increased data requirements
to ensure the alternatives are well studied
and safer than the substances being replaced.
Consequently, short-chain PFASs are some
of the most robustly studied new chemicals
introduced to the market, having undergone
years of toxicity and environmental testing
at the request of regulators. Industry continues this collaboration with regulators,
developing additional data on the alternatives
and working to make those data publicly
available, including on the FluoroCouncil
website (http://www.f luorocouncil.org/
Resources/Research). Based on this robust
body of data, regulators globally have determined the alternatives are safe for their
intended use. The “sustainable and less hazardous alternatives” sought by the Madrid
Statement authors already exist in the form of
short-chain PFASs.
We continue to be perplexed by assertions from the authors of the Madrid
Statement that short-chain PFASs present
hazards comparable to those of long-chain
PFASs, citing publications such as Bull et al.
(2014) and Wang et al. (2015). These publications suffer from important data gaps, such
as the failure to cite key published articles
on the toxicity of short-chain PFASs (e.g.,
Klaunig et al. [2015], which presents animal data indicating perfluorohexanoic acid is
not carcinogenic). Furthermore, these publications actually acknowledge or demonstrate that many of the leading short-chain
PFASs are less bioaccumulative and less toxic
than the long-chain PFASs with which they
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have been compared, based on the available data taken as a whole. This conclusion,
which is well accepted by regulatory agencies
such as the EPA, compels a different policy
outcome than the Madrid Statement suggests. The first priority for risk management
should be phase-out of the long-chain PFASs.
Attempting to broaden that phase-out to
effective alternatives that are less hazardous
can only create a technological impasse that
supports the retention of long-chain PFASs
in the marketplace.
The authors of the Madrid Statement also
contend that PFASs are not critical to modern life. The importance of PFAS chemistry, however, was long ago determined by the
market. Industries relying on PFASs evaluated
fluorinated and nonfluorinated alternatives,
as well as alternative technology, and decided
on the products that met their specifications
and performance needs. Some decisions
involved continuing to use PFASs because
they meet performance needs that nonfluorinated alternatives cannot. For example,
first-responder protective gear is treated with
fluorinated products to help maintain performance in fires; firefighting foam produced
with fluorinated surfactants provides shorter
extinguishment times and critical burnback
resistance when fighting flammable liquid
fires; and hospital gowns, drapes, and divider
curtains rely on fluorinated polymers to provide protective barriers against transmission
of diseases. Because the short-chain PFASs
have been reviewed and approved by regulatory authorities globally, all applications relying on these substances can be used without
presenting a significant risk.
The largest use of short-chain PFASs is
for polymeric products. These products—
like other polymers—are quite stable under
environmental conditions. The resilience
of short-chain PFASs is directly connected
to its performance, providing long-lasting,
durable properties. First responders, medical
personnel, and patients would certainly not
want the properties in safety gear or medical garments to quickly become ineffective.
Even when the short-chain PFASs, which
do not present a significant risk, are used
in what some people may characterize as
“nonessential applications,” such as clothing
and furniture, these substances significantly
extend the effective lifetime of those products, meaning less waste, infrequent washings, and economic savings. These benefits of
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short-chain PFASs can be further enhanced
by reducing emissions through the adoption
of best environmental practices, which the
FluoroCouncil has identified and is encouraging in the supply chain.
The FluoroCouncil members remain
committed to science-based stewardship
activities, including continually enhancing
the sustainability of their chemistries and
products by improving their environmental, health, safety, and performance profiles.
We are open to working collaboratively and
constructively with stakeholders on 1) strategies to complete the global transition away
from long-chain PFASs, 2) identification of
issues that warrant further data development
and risk assessment, 3) actions that can foster
additional stewardship activities within the
supply chain, and 4) best methods for transparently sharing information relevant to the
health and environmental impact of PFASs.

The author is employed by the American
Chemistr y Council and manages the
FluoroCouncil, a global organization representing the world’s leading fluorotechnology companies. The members of the FluoroCouncil are
Archroma Management LLC, Arkema France,
Asahi Glass Co., Ltd., Daikin Industries, Ltd.,
Solvay Specialty Polymers, and The Chemours
Company LLC.
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